Arcturus Therapeutics Holdings Inc is a biotechnology company focused on the development of transformative RNA medicines

The company utilizes its proprietary platform to create innovative therapies targeting various diseases, including infectious diseases and genetic disorders. By leveraging advanced technologies, such as self-amplifying mRNA and lipid nanoparticle delivery systems, Arcturus aims to improve the efficacy and safety of vaccines and therapeutics. Their pipeline includes candidates designed for both human and veterinary applications, reflecting their commitment to addressing significant unmet medical needs and enhancing patient outcomes.